Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...
7d
News Medical on MSNGLP-1 Antidiabetic Drugs Spark Eye Health ConcernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
8d
Civic Science on MSNGLP-1 Trends by CivicScience: GLP-1 Users Foresee Long-Term Use, Spending More on Clothing and Groceries, Plus MoreThis is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on over ...
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results